Abstract | BACKGROUND/AIMS: METHODS: In this single-centre interventional case series, 151 consecutive eyes with keratoconus underwent modified microkeratome-assisted LK. Eyes with scars extending beyond the posterior half of the corneal stroma and preoperative thinnest-point pachymetry value of less than 300 μm were excluded. Outcome measures were best spectacle-corrected visual acuity (BSCVA), refractive astigmatism (RA), endothelial cell density, immunological rejection, ectasia recurrence and graft failure rates. RESULTS: Baseline BSCVA (0.89±0.31 logarithm of the minimum angle of resolution (logMAR)) significantly improved to 0.10±0.12 logMAR at year 3 (p<0.001), and remained stable up to 10 years. At 10 years, 94% of eyes saw ≥20/40, 61% saw ≥20/25 and 24% saw ≥20/20 Snellen BSCVA. At final follow-up, RA exceeding 4.5 dioptres was observed in 5 cases (4%). Endothelial cell loss was 25±17% at 1 year with an annual decline of 2% over 10 years. The 10-year cumulative risk for immunological rejection and graft failure was 8.5%, and 2.4%, respectively. No case developed recurrent ectasia at 10 years. CONCLUSION: Modified microkeratome-assisted LK results in stable visual and refractive outcomes with low rates of immunological rejection and graft failure in the absence of recurrence of ectasia for at least 10 years.
|
Authors | Angeli Christy Yu, Elena Franco, Lorenzo Caruso, James Myerscough, Rossella Spena, Fiorella Fusco, Sergiu Socea, Cristina Bovone, Massimo Busin |
Journal | The British journal of ophthalmology
(Br J Ophthalmol)
Vol. 105
Issue 12
Pg. 1651-1655
(12 2021)
ISSN: 1468-2079 [Electronic] England |
PMID | 33011685
(Publication Type: Journal Article)
|
Copyright | © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
Topics |
- Corneal Transplantation
(methods)
- Dilatation, Pathologic
- Follow-Up Studies
- Humans
- Keratoconus
(surgery)
- Keratoplasty, Penetrating
(methods)
- Refraction, Ocular
- Retrospective Studies
- Treatment Outcome
|